During the past decade, Kansas Gastroenterology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kansas Gastroenterology" are "Ulcerative" (1 trials), "Ulcerative Colitis" (1 trials), "Ulcerative Colitis Acute" (1 trials), "Ulcerative Colitis Flare" (1 trials) and "Ulcerative Colitis and Crohn's Disease" (1 trials). Many other conditions were trialed in "Kansas Gastroenterology" in a lesser frequency.

Most popular intervention types in "Kansas Gastroenterology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Other Biologic Agents" (1 trials), "PL8177" (1 trials), "PL8177 Placebo" (1 trials) and "Vedolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kansas Gastroenterology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kansas Gastroenterology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kansas Gastroenterology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kansas Gastroenterology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".